Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines

Oncogene

Volumn 24, Issue 12, 2005, Pages 2050-2058

  Izeradjene, Kamel ^a   Douglas, Leslie ^a   Delaney, Addison ^a   Houghton, Janet A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Apoptosis; CK2; DISC; TRAIL

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ADAPTOR PROTEIN; CASEIN KINASE 2ALPHA; CASEIN KINASE II; CASPASE; CASPASE 8; DEATH INDUCING SIGNALING COMPLEX PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; PROTEIN BID; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; APIGENIN; APOPTOSIS REGULATORY PROTEIN; BISINDOLYLMALEIMIDE; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; ENZYME INHIBITOR; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL PROTECTION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; SENSITIZATION; ADENOCARCINOMA; CELL DEATH; COLON TUMOR; DRUG EFFECT; GENE VECTOR; KINETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; APIGENIN; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASEIN KINASE II; CELL DEATH; CELL LINE, TUMOR; COLONIC NEOPLASMS; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; ENZYME INHIBITORS; GENETIC VECTORS; HUMANS; INDOLES; KINETICS; MALEIMIDES; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16444382571     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208397     Document Type: Article

References (43)

1. Allende JE and Allende CC. (1995). FASEB J., 9, 313-323.
2. Almasan A and Ashkenazi A. (2003). Cytokine Growth Factor Rev., 14, 337-348.
3. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
4. Beg AA, Sha WC, Bronson RT and Baltimore D. (1995). Genes Dev., 9, 2736-2746.
5. Bernard D, Quatannens B, Vandenbunder B and Abbadie C. (2001). J. Biol. Chem., 276, 27322-27328.
6. Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, Hochmann A, Journot L, Antonsson B and Martinou JC. (2001). Mol. Cell, 8, 601-611.
7. Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM and Jeremias I. (2003). Oncogene, 22, 3842-3852.
8. Faust RA, Niehans G, Gapany M, Hoistad D, Knapp D, Cherwitz D, Davis A, Adams GL and Ahmed K. (1999). Int. J. Biochem. Cell Biol., 31, 941-949.
9. Griffith TS, Chin WA, Jackson GC, Lynch DH and Kubin MZ. (1998). J. Immunol., 161, 2833-2840.
10. Griffith TS and Lynch DH. (1998). Curr. Opin. Immunol., 10, 559-563.
11. Guo C, Yu S, Davis AT, Wang H, Green JE and Ahmed K. (2001). J. Biol. Chem., 276, 5992-5999.
12. Hofmann K, Bucher P and Tschopp J. (1997). Trends Biochem. Sci., 22, 155-156.
13. Holmstrom TH and Eriksson JE. (2000). Crit. Rev. Immunol., 20, 121-152.
14. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC, Krammer PH and Eriksson JE. (2000). EMBO J., 19, 5418-5428.
15. Jeremias I and Debatin KM. (1998). Eur. Cytokine Network, 9, 687-688.
16. Keane MM, Rubinstein Y, Cuello M, Ettenberg SA, Banerjee P, Nau MM and Lipkowitz S. (2000). Breast Cancer Res. Treat., 64, 211-219.
17. Kikkawa U, Mann SK, Firtel RA and Hunter T. (1992). Mol. Cell. Biol., 12, 5711-5723.
18. Krippner-Heidenreich A, Talanian RV, Sekul R, Kraft R, Thole H, Ottleben H and Luscher B. (2001). Biochem. J., 358, 705-715.
19. Lacour S, Micheau O, Hammann A, Drouineaud V, Tschopp J, Solary E and Dimanche-Boitrel MT. (2003). Oncogene, 22, 1807-1816.
20. Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD and Seldin DC. (2001). Oncogene, 20, 3247-3257.
21. Lee KA, Bindereif A and Green MR. (1988). Gene Anal. Tech., 5, 22-31.
22. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD and Ashkenazi A. (1996). Curr. Biol., 6, 750-752.
23. McElhinny JA, Trushin SA, Bren GD, Chester N and Paya CV. (1996). Mol. Cell. Biol., 16, 899-906.
24. Munstermann U, Fritz G, Seitz G, Lu YP, Schneider HR and Issinger OG. (1990). Eur. J. Biochem., 189, 251-257.
25. Padmanabha R, Chen-Wu JL, Hanna DE and Glover CV. (1990). Mol. Cell. Biol., 10, 4089-4099.
26. Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, Cunningham JM and Nienhuis AW. (1999). Blood, 93, 488-499.
27. Petak I, Vernes R, Szucs KS, Anozie M, Izeradjene K, Douglas L, Tillman DM, Phillips DC and Houghton JA. (2003). Cell Death Differ., 10, 729-739.
28. Ravi R and Bedi A. (2002). Cancer Res., 62, 4180-4185.
29. Romieu-Mourez R, Landesman-Bollag E, Seldin DC and Sonenshein GE. (2002). Cancer Res., 62, 6770-6778.
30. Ruzzene M, Penzo D and Pinna LA. (2002). Biochem. J., 364, 41-47.
31. Sarker M, Ruiz-Ruiz C and Lopez-Rivas A. (2001). Cell Death Differ., 8, 172-181.
32. Sarker M, Ruiz-Ruiz C, Robledo G and Lopez-Rivas A. (2002). Oncogene, 21, 4323-4327.
33. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME. (1998). EMBO J., 17, 1675-1687.
34. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH and Peter ME. (1999). J. Biol. Chem., 274, 22532-22538.
35. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N and Tschopp J. (1997). Immunity, 7, 831-836.
36. Sun XM, Bratton SB, Butterworth M, MacFarlane M and Cohen GM. (2002). J. Biol. Chem., 277, 11345-11351.
37. Tillman DM, Harwood FG, Gibson AA and Houghton JA. (1998). Cell Death Differ., 5, 450-457.
38. Trauzold A, Wermann H, ArIt A, Schutze S, Schafer H, Oestern S, Roder C, Ungefroren H, Lampe E, Heinrich M, Walczak H and Kalthoff H. (2001). Oncogene, 20, 4258-4269.
39. Varadhachary AS, Edidin M, Hanlon AM, Peter ME, Krammer PH and Salgame P. (2001). J. Immunol., 166, 6564-6569.
40. Wajant H, Johannes FJ, Haas E, Siemienski K, Schwenzer R, Schubert G, Weiss T, Grell M and Scheurich P. (1998). Curr. Biol., 8, 113-116.
41. Wang D, Westerheide SD, Hanson JL and Baldwin Jr AS. (2000). J. Biol. Chem., 275, 32592-32597.
42. Wang H, Davis A, Yu S and Ahmed K. (2001). Mol. Cell. Biochem., 227, 167-174.
43. Xu X, Toselli PA, Russell LD and Seldin DC. (1999). Nat. Genet., 23, 118-121.